OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001420030

Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. (CIK 0001420030, EIN 20-5863618) reported revenue of $5.26 million ($5,260,941) for FY2015 (2015-01-01 to 2015-12-31) and net income of -$3.04 million (-$3,043,810) for FY2015 (2015-01-01 to 2015-12-31), as filed in its 10-K filed 2016-04-14 (accession 0001493152-16-008933).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 9).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001420030
EIN20-5863618
SIC industry code2834 Pharmaceutical Preparations
Fiscal year endDecember 9
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_65zp4b302m1ym0mwe37k61ms7s
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$5,260,941FY20152015-01-01 to 2015-12-3110-K2016-04-140001493152-16-008933Revenues
Net income-$3,043,810FY20152015-01-01 to 2015-12-3110-K2016-04-140001493152-16-008933NetIncomeLoss
Total assets$2,427,110FY2015as of 2015-12-3110-K2016-04-140001493152-16-008933Assets
Total liabilities$15,345,981FY2015as of 2015-12-3110-K2016-04-140001493152-16-008933Liabilities
Stockholders' equity-$12,895,489FY2015as of 2015-12-3110-K2016-04-140001493152-16-008933StockholdersEquity
Operating cash flow-$1,278,617FY20152015-01-01 to 2015-12-3110-K2016-04-140001493152-16-008933NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.11 per shareFY20152015-01-01 to 2015-12-3110-K2016-04-140001493152-16-008933EarningsPerShareBasicAndDiluted
Shares outstanding30,185,727 sharesFY2015as of 2016-04-1310-K2016-04-140001493152-16-008933EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2006-2015, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20152015-01-01 to 2015-12-31$5,260,94110-K2016-04-140001493152-16-008933
RevenueFY20142014-01-01 to 2014-12-31$7,112,35910-K2016-04-140001493152-16-008933
RevenueFY20132013-01-01 to 2013-12-31$9,555,56210-K2015-04-150001493152-15-001421
RevenueFY20122012-01-01 to 2012-12-31$7,296,40110-K2014-03-310001493152-14-000948
RevenueFY20112011-01-01 to 2011-12-31$8,809,66810-K2013-04-010001144204-13-019247
Net incomeFY20152015-01-01 to 2015-12-31-$3,043,81010-K2016-04-140001493152-16-008933
Net incomeFY20142014-01-01 to 2014-12-31-$3,895,00910-K2016-04-140001493152-16-008933
Net incomeFY20132013-01-01 to 2013-12-31-$9,337,61810-K2015-04-150001493152-15-001421
Net incomeFY20122012-01-01 to 2012-12-31-$9,586,18210-K2014-03-310001493152-14-000948
Net incomeFY20112011-01-01 to 2011-12-31-$4,177,05010-K2013-04-010001144204-13-019247

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2016-04-142015-12-310001493152-16-008933form10-k.htm
10-Q2015-11-132015-09-300001493152-15-005455form-10q.htm
10-Q2015-08-142015-06-300001493152-15-003658form10-q.htm
10-Q2015-05-152015-03-310001493152-15-001998form10-q.htm
10-K2015-04-152014-12-310001493152-15-001421form10-k.htm
10-Q2014-11-142014-09-300001493152-14-003731form10q.htm
10-Q2014-08-142014-06-300001493152-14-002549form10q.htm
10-Q2014-05-202014-03-310001493152-14-001648form10q.htm
10-K2014-03-312013-12-310001493152-14-000948form10k.htm
10-Q2013-11-132013-09-300001144204-13-061055v359341_10q.htm
10-Q2013-08-142013-06-300001144204-13-045999v351557_10q.htm
10-Q2013-05-152013-03-310001144204-13-029593v343939_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001420030published by the sourcedata.sec.gov/submissions/CIK0001420030.json2026-10-21
Employer Identification Number (EIN) · US-EIN20-5863618published by the sourcedata.sec.gov/submissions/CIK0001420030.json2026-10-21

Former names

NameFromTo
AFH Acquisition III, Inc.2008-02-012011-01-31

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001420030.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001420030.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001420030" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001420030/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001420030/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1420030"}

On SEC EDGAR

About this data